Preferred Label : Olmesartan Medoxomil;

MeSH definition : An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.;

MeSH synonym : Medoxomil, Olmesartan; 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346;

CISMeF synonym : Benicar HCT; HCT, Benicar; 866, CS; Olmetec;

MeSH hyponym : CS 866; votum; benicar; CS-866; CS866;

MeSH Related Number : 144689-24-7 (olmesartan medoxomil);

Wikipedia link : https://en.wikipedia.org/wiki/Votum;

Is substance : O;

UNII : 6M97XTV3HD;

Details


Main resources

You can consult :

An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.

https://www.has-sante.fr/jcms/p_3409800/fr/alteis-olmesartan-medoxomil
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
olmesartan medoxomil
antihypertensive agents
hypertension
adult
evaluation of the transparency committee
Olmesartan Medoxomil

---
http://www.has-sante.fr/portail/jcms/c_2658552/fr/coolmetec
2016
false
France
French
antihypertensive agents
angiotensin II type 1 receptor blockers
risk assessment
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
administration, oral
angiotensin II type 1 receptor blockers
antihypertensive agents
sodium chloride symporter inhibitors
hydrochlorothiazide
diuretics
olmesartan medoxomil and diuretics
insurance, health, reimbursement
hypertension
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2658537/fr/alteisduo
2016
false
France
French
treatment outcome
intestinal diseases
angiotensin II type 1 receptor blockers
antihypertensive agents
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
insurance, health, reimbursement
administration, oral
olmesartan medoxomil and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2620725/fr/medicaments-de-l-hypertension-arterielle-a-base-d-olmesartan-pourquoi-ne-sont-ils-plus-rembourses-quelle-conduite-a-tenir
2016
false
false
false
France
French
Olmesartan Medoxomil
Olmesartan Medoxomil
administration, oral
insurance, health, reimbursement
guidelines for drug use
drug combinations
olmesartan medoxomil
olmesartan medoxomil and diuretics
olmesartan medoxomil and amlodipine
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
hydrochlorothiazide
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
antihypertensive agents
antihypertensive agents
hypertension
intestinal diseases
Therapy change

---
http://www.has-sante.fr/portail/jcms/c_2579425/fr/coolmetec
2015
false
France
French
antihypertensive agents
angiotensin II type 1 receptor blockers
risk assessment
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
administration, oral
angiotensin II type 1 receptor blockers
antihypertensive agents
sodium chloride symporter inhibitors
hydrochlorothiazide
diuretics
olmesartan medoxomil and diuretics
insurance, health, reimbursement
hypertension
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2579422/fr/olmetec
2015
false
France
French
treatment outcome
angiotensin II type 1 receptor blockers
antihypertensive agents
risk assessment
Olmesartan Medoxomil
Olmesartan Medoxomil
administration, oral
insurance, health, reimbursement
antihypertensive agents
angiotensin II type 1 receptor blockers
hypertension
olmesartan medoxomil
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2579413/fr/alteisduo
2015
false
France
French
treatment outcome
intestinal diseases
angiotensin II type 1 receptor blockers
antihypertensive agents
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
insurance, health, reimbursement
administration, oral
olmesartan medoxomil and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2036404/fr/coolmetec
http://www.has-sante.fr/portail/jcms/c_1019667/coolmetec-gamme
http://www.has-sante.fr/portail/jcms/c_2036404/fr/coolmetec-olmesartan/hydrochlorothiazide
2015
false
France
French
guidelines for drug use
antihypertensive agents
angiotensin II type 1 receptor blockers
risk assessment
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
administration, oral
angiotensin II type 1 receptor blockers
antihypertensive agents
sodium chloride symporter inhibitors
hydrochlorothiazide
diuretics
olmesartan medoxomil and diuretics
insurance, health, reimbursement
hypertension
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2036407/fr/alteisduo
http://www.has-sante.fr/portail/jcms/c_2036407/fr/alteisduo-olmesartan/hydrochlorothiazide
2015
false
France
French
treatment outcome
intestinal diseases
angiotensin II type 1 receptor blockers
antihypertensive agents
guidelines for drug use
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
insurance, health, reimbursement
administration, oral
olmesartan medoxomil and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2579410/fr/alteis
2015
false
France
French
treatment outcome
risk assessment
angiotensin II type 1 receptor blockers
antihypertensive agents
Olmesartan Medoxomil
Olmesartan Medoxomil
angiotensin II type 1 receptor blockers
antihypertensive agents
administration, oral
olmesartan medoxomil
insurance, health, reimbursement
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2036416/fr/olmetec
http://www.has-sante.fr/portail/jcms/c_793472/olmetec
http://www.has-sante.fr/portail/jcms/c_2036416/fr/olmetec-olmesartan
2015
false
France
French
treatment outcome
guidelines for drug use
angiotensin II type 1 receptor blockers
antihypertensive agents
risk assessment
Olmesartan Medoxomil
Olmesartan Medoxomil
administration, oral
insurance, health, reimbursement
antihypertensive agents
angiotensin II type 1 receptor blockers
hypertension
olmesartan medoxomil
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2036419/fr/alteis
http://www.has-sante.fr/portail/jcms/c_793454/alteis
http://www.has-sante.fr/portail/jcms/c_2036419/fr/alteis-olmesartan
2015
false
France
French
treatment outcome
risk assessment
guidelines for drug use
angiotensin II type 1 receptor blockers
antihypertensive agents
Olmesartan Medoxomil
Olmesartan Medoxomil
angiotensin II type 1 receptor blockers
antihypertensive agents
administration, oral
olmesartan medoxomil
insurance, health, reimbursement
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-06/coolmetec_-_ct-8103.pdf
http://www.has-sante.fr/portail/jcms/c_962466/coolmetec
2010
false
France
French
Olmesartan Medoxomil
angiotensin II type 1 receptor blockers
treatment outcome
drug combinations
olmesartan medoxomil and diuretics
administration, oral
hydrochlorothiazide
insurance, health, reimbursement
hypertension
diuretics
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_962483/alteisduo
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-06/alteis_duo_-_ct-8132.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-09/alteisduo_ct_8132.pdf
2010
false
France
French
English
Olmesartan Medoxomil
olmesartan medoxomil and diuretics
insurance, health, reimbursement
drug combinations
hydrochlorothiazide
administration, oral
diuretics
angiotensin II type 1 receptor blockers
antihypertensive agents
hypertension
evaluation of the transparency committee

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Olmetec-Plus_May-27-2009_f.pdf
2009
false
Canada
French
Olmesartan Medoxomil
antihypertensive agents
drug combinations
hydrochlorothiazide
angiotensin II type 1 receptor blockers
treatment outcome
diuretics
tablets
administration, oral
drug evaluation

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Olmetec_May-27-2009_f.pdf
2009
false
Canada
French
Olmesartan Medoxomil
Olmesartan Medoxomil
antihypertensive agents
angiotensin II type 1 receptor blockers
treatment outcome
insurance, health, reimbursement
administration, oral
tablets
drug costs
olmesartan medoxomil
drug evaluation

---
https://rmlg.uliege.be/article/1564
2007
false
Belgium
French
Olmesartan Medoxomil
diuretics
sodium chloride symporter inhibitors
hydrochlorothiazide
angiotensin II type 1 receptor blockers
antihypertensive agents
drug combinations
hypertension
treatment outcome
olmesartan medoxomil and diuretics
journal article
drug information

---
http://www.has-sante.fr/portail/display.jsp?id=c_400962
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032542.pdf
2006
false
France
French
Olmesartan Medoxomil
drug combinations
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
insurance, health, reimbursement
administration, oral
olmesartan medoxomil and diuretics
hypertension
evaluation of the transparency committee

---
https://rmlg.uliege.be/article/1134
2004
false
Belgium
French
Olmesartan Medoxomil
Olmesartan Medoxomil
hypertension
antihypertensive agents
angiotensin II type 1 receptor blockers
antihypertensive agents
angiotensin II type 1 receptor blockers
olmesartan medoxomil
drug information
journal article

---
Nous contacter.
26/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.